Dr Kaouthar Louati, University of Monastir, Tunisia
Dr. Kaouthar Louati is a distinguished researcher and analytical chemist 🎓🧪 with a doctoral degree in Analytical Chemistry from the University of Monastir, Tunisia 🇹🇳. She has made substantial contributions to pharmaceutical sciences through over 15 high-impact publications 📚, two book contributions 📘, and collaborative projects in Tunisia and the UK 🇬🇧. Her work focuses on toxicoproteomics, redox proteomics, and stability studies of pharmaceuticals 💊. Dr. Louati is affiliated with prestigious institutions including the University of Nottingham, Habib Bourguiba University Hospital, and multiple pharmaceutical laboratories 🏥🔬. Known for her meticulous method validation, drug impurity analysis, and environmental toxicology studies 🌿⚗️, she has emerged as a key figure in analytical method development and toxicological risk assessment. With deep academic commitment and a passion for pharmaceutical innovation 💡, she continues to impact the global scientific community and serves as a role model for women in STEM 👩🔬🌍.
Publication Profile
Orcid
Education
Dr. Louati’s academic journey is rooted in excellence 🌟. She earned her Doctorate in Analytical Chemistry (2019–2024) 🧪 from the University of Monastir, Tunisia, with very honorable distinction 🎓. Previously, she completed a Master’s in Medicaments’ Research and Development (2009–2010) 🧬 and a Diploma in Doctor of Pharmacy (2008–2009), both with high honors 🏅. Her early academic path included a Diploma in Pharmacy (2002–2007) with a very good grade 🧑⚕️ and a Mathematics Baccalaureate (2002) with very honorable mention 🧠➕➖. Throughout her education, she displayed strong scientific aptitude, particularly in pharmaceutical formulation, analytical chemistry, and medical science fundamentals 💉📘. This rich academic foundation positioned her to excel in multidisciplinary pharmaceutical research, bridging clinical applications with laboratory innovation 🧫🔍.
Experience
Dr. Louati has extensive experience in academia, hospitals, and the pharmaceutical industry 🏥🏭. Since 2020, she has served as a Doctor Pharmacist and Associate Researcher at the University of Monastir’s Laboratory of Pharmacology and Drug Development 🔬, and at the Habib Bourguiba University Hospital in both the pharmaceutical and pathological anatomy departments 🧑⚕️🧫. She also contributed internationally at the University of Nottingham and Royal Derby Hospital, UK (2020–2023) 🇬🇧. From 2010 to 2015, she worked in UNIMED and PHARMACARE Laboratories, where she developed generic drugs, validated analytical methods, and ensured product compliance with international pharmacopeias 💊📈. Her expertise spans method validation (ICH Q2R1), stress testing, impurity profiling, and regulatory documentation ✍️📑. Her collaborative approach and technical leadership across diverse settings underscore her excellence as both a researcher and pharmaceutical scientist 🌍🧪.
Awards and Honors
Dr. Kaouthar Louati has earned academic distinction throughout her career, including “Very Honorable” mentions for both her doctoral and master’s studies 🏅📘. She was recognized for producing highly cited research and has published over 15 peer-reviewed articles and 2 books in respected international journals and editions 📚🌐. Her contributions to method development, toxicological evaluation, and environmental health have received national and international attention 🧬🌍. Her scientific rigor earned her opportunities to collaborate with global institutions such as the University of Nottingham, reflecting peer recognition and trust in her expertise 🤝🔬. Her work on toxicoproteomics and pharmaceutical impurities has made significant impacts on public health research and regulatory science 🌡️⚗️. Dr. Louati’s continued academic excellence, innovation, and mentorship potential position her as a prime candidate for the Best Researcher Award 🏆🎖️.
Research Focus
Dr. Louati’s research is at the forefront of analytical chemistry, toxicoproteomics, and pharmaceutical sciences 🔍🧪. She focuses on validating and developing robust analytical methods to detect drug impurities, residual solvents, and degradation products, essential for drug stability and safety studies 💊📈. Her work in toxicoproteomics includes assessing oxidative stress and protein damage induced by environmental toxins like pesticides using cutting-edge techniques like Nano-UHPLC-MS/MS and 2D-SDS-PAGE 🌿🧬. She also pioneers method development for anti-epileptic drug monitoring and anabolic steroid detection for doping control 🧠💪. Her integration of redox biology and pharmacological analytics strengthens both environmental health surveillance and clinical pharmacology 🌎🏥. Dr. Louati’s unique blend of expertise bridges fundamental research with real-world applications, significantly contributing to public health, pharmacovigilance, and regulatory standards 🌐📊.
Publication Top Notes